Implementation of melanoma guidelines in the multidisciplinary setting: A qualitative analysis

Am J Surg. 2023 Feb;225(2):335-340. doi: 10.1016/j.amjsurg.2022.09.039. Epub 2022 Sep 25.

Abstract

Background: Data suggest variation in utilization of completion lymph node dissection (CLND) and adjuvant systemic therapy (AT) for sentinel lymph node-positive melanoma. We aimed to explore how clinicians consider multidisciplinary treatment options.

Methods: We conducted semi-structured interviews of surgical oncologists, medical oncologists, and otolaryngologists to produce a thematic analysis.

Results: Participants (n = 26) described melanoma care as inherently "multidisciplinary," noting the importance of conversations facilitated by shared clinic days or space. Despite believing that their practice mirrored other clinicians, participants revealed diverging perspectives on CLND and AT. Multidisciplinary care presented challenges for surveillance as surgeons expressed desire to retain ownership of patients but did not feel comfortable overseeing AT needs. Participants questioned the fidelity of nodal ultrasounds, noted redundancy in their roles, and described a "surveillance burden" for patients.

Conclusion: Opportunities exist to improve multidisciplinary melanoma care through broader consensus of how to translate emerging data into patient care and delineating surveillance roles.

Keywords: Adjuvant therapy; Completion lymph node dissection; Implementation; Melanoma; Multidisciplinary.

MeSH terms

  • Humans
  • Lymph Node Excision
  • Melanoma* / pathology
  • Melanoma* / surgery
  • Sentinel Lymph Node Biopsy
  • Sentinel Lymph Node* / pathology
  • Skin Neoplasms* / pathology
  • Skin Neoplasms* / surgery